XML 40 R4.htm IDEA: XBRL DOCUMENT v2.4.1.9
Condensed Statements of Income (Unaudited) (USD $)
3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Product sales, net $ 2,770,204us-gaap_SalesRevenueGoodsNet $ 2,620,834us-gaap_SalesRevenueGoodsNet
Cost of products sold 933,148us-gaap_CostOfGoodsSold 882,997us-gaap_CostOfGoodsSold
Gross profit 1,837,056us-gaap_GrossProfit 1,737,837us-gaap_GrossProfit
Selling, general and administrative expenses 1,898,081us-gaap_SellingGeneralAndAdministrativeExpense 1,392,869us-gaap_SellingGeneralAndAdministrativeExpense
Research and development expenses 10,118us-gaap_ResearchAndDevelopmentExpense 15,720us-gaap_ResearchAndDevelopmentExpense
Total operating expenses 1,908,199us-gaap_OperatingExpenses 1,408,589us-gaap_OperatingExpenses
(Loss) income from operations (71,143)us-gaap_OperatingIncomeLoss 329,248us-gaap_OperatingIncomeLoss
Other income (expenses)    
Interest expense 1,210us-gaap_InterestExpense (475)us-gaap_InterestExpense
Total other expenses, net (356,491)us-gaap_NonoperatingIncomeExpense (134,414)us-gaap_NonoperatingIncomeExpense
(Loss) income before provision for income taxes (427,634)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest 194,834us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Net loss attributable to the noncontrolling interests 8,259us-gaap_NetIncomeLossAttributableToNoncontrollingInterest  
Net (loss) income attributable to Milestone Scientific Inc (419,375)us-gaap_NetIncomeLoss 194,834us-gaap_NetIncomeLoss
Net (loss) income per share applicable to common stockholders -    
Basic $ (0.02)us-gaap_EarningsPerShareBasic $ 0.01us-gaap_EarningsPerShareBasic
Diluted $ (0.02)us-gaap_EarningsPerShareDiluted $ 0.01us-gaap_EarningsPerShareDiluted
Weighted average shares outstanding and to be issued -    
Basic 22,346,114us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 17,787,352us-gaap_WeightedAverageNumberOfSharesOutstandingBasic
Diluted 22,346,114us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 18,268,814us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding
Medical Joint Venture    
Other income (expenses)    
Gain (Loss) on Earnings from joint venture (450,160)us-gaap_IncomeLossFromEquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= mlss_MedicalJointVentureMember
(130,523)us-gaap_IncomeLossFromEquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= mlss_MedicalJointVentureMember
Education Joint Venture    
Other income (expenses)    
Gain (Loss) on Earnings from joint venture (4,215)us-gaap_IncomeLossFromEquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= mlss_EducationJointVentureMember
(3,416)us-gaap_IncomeLossFromEquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= mlss_EducationJointVentureMember
China Joint Venture    
Other income (expenses)    
Gain (Loss) on Earnings from joint venture $ 96,674us-gaap_IncomeLossFromEquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= mlss_ChinaJointVentureMember